Citation Impact
Citing Papers
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Loci
1989
Direct Removal of Alkylation Damage from DNA by AlkB and Related DNA Dioxygenases
2006 StandoutNobel
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
2008 Standout
Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase
2001
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Demethylation of 3-Methylthymine in DNA by Bacterial and Human DNA Dioxygenases
2004 StandoutNobel
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
High throughput assay for cytochrome P450 BM3 for screening libraries of substrates and combinatorial mutants
2002
Protein engineering of oxygenases for biocatalysis
2002 StandoutNobel
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Ethanol‐induced cytochrome P4502E1 causes carcinogenic etheno‐DNA lesions in alcoholic liver disease†‡
2009
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
2005
Interindividual Variability of the Clinical Pharmacokinetics of Methadone
2002
Cost-Effective Whole-Cell Assay for Laboratory Evolution of Hydroxylases in Escherichia coli
2001 StandoutNobel
Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi
2001 StandoutNature
Preparation of human metabolites of propranolol using laboratory‐evolved bacterial cytochromes P450
2005 StandoutNobel
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
CYP2E1 and risk of chemically mediated cancers
2010
Global incorporation of norleucine in place of methionine in cytochrome P450 BM‐3 heme domain increases peroxygenase activity
2003 StandoutNobel
Laboratory evolution of cytochrome P450 BM‐3 monooxygenase for organic cosolvents
2003 StandoutNobel
Oral Anticoagulant Therapy
2012 Standout
Head and neck cancer
2008 Standout
Lipids of Three Microsporidian Species and Multivariate Analysis of the Host–Parasite Relationship
2001
A Continuous Spectrophotometric Assay for P450 BM-3, a Fatty Acid Hydroxylating Enzyme, and Its Mutant F87A
1999
Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase
2002
Clomethiazole (Zendra®) in Acute Ischemic Stroke Basic Pharmacology and Biochemistry and Clinical Efficacy
1998
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
A Self‐Sufficient Peroxide‐Driven Hydroxylation Biocatalyst
2003 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Cancer-associated cachexia
2018 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Genetic susceptibility–molecular epidemiology of head and neck cancer
2002
CYP2E1: from ASH to NASH
2003
Alcoholic liver disease: New insights in pathogenesis lead to new treatments
2000
Mechanisms that regulate production of reactive oxygen species by cytochrome P450
2004
The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans
2007
Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity
2009
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Excretion of formaldehyde, malondialdehyde, acetaldehyde and acetone in the urine of rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin, paraquat, endrin and carbon tetrachloride
1992
Effect of Tenofovir Disoproxil Fumarate on the Pharmacokinetics and Pharmacodynamics of Total, R‐, and S‐Methadone
2004
Epidemiology, Staging, and Screening of Head and Neck Cancer
2006
Oxidative mechanisms in the toxicity of metal ions
1995 Standout
Predicting the mutagenicity of tobacco‐related N‐nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH–cytochrome P450 reductase
2001
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
Glutathione synthesis
2012 Standout
Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
1997
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: A review and roadmap for research
2007 Standout
Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
2002 Standout
Prevention of head and neck cancer: Current status and future prospects
2004
Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney
2000
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Cocarcinogenic effects of alcohol in hepatocarcinogenesis
2002
Reactive oxygen species, cellular redox systems, and apoptosis
2010 Standout
Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components
2001
Human Cannabinoid Pharmacokinetics
2007 Standout
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase
2002 StandoutNobel
The Myofibroblast
2007 Standout
Repairing DNA-methylation damage
2004
Alcoholic steatohepatitis
2010
Engineered Alkane‐Hydroxylating Cytochrome P450BM3 Exhibiting Nativelike Catalytic Properties
2007 StandoutNobel
ASCORBATE AND GLUTATHIONE: Keeping Active Oxygen Under Control
1998 Standout
Identification of acrylate, the product of the dehydration of (R)‐lactate catalysed by cell‐free extracts from Clostridium propionicum
1985
Enantioselective α-Hydroxylation of 2-Arylacetic Acid Derivatives and Buspirone Catalyzed by Engineered Cytochrome P450 BM-3
2006 StandoutNobel
Involvement of Cytochromes P-450 2E1 and 3A4 in the 5-Hydroxylation of Salicylate in Humans
1999
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
The Free Radical Theory of Aging Matures
1998 Standout
Chemical Routes for the Transformation of Biomass into Chemicals
2007 Standout
Quantitative gas chromatographic determination of perfluorooctanoic acid as the benzyl ester in plasma and urine
1985
Regulation of γ-glutamylcysteine synthetase by protein phosphorylation
1996
Repair and Genetic Consequences of Endogenous DNA Base Damage in Mammalian Cells
2004 StandoutNobel
Cytochrome P-450-catalyzed hydroxylation and carboxylic acid ester cleavage of Hantzsch pyridine esters.
1988
Compound-Specific, Quantitative Characterization of Organic Fluorochemicals in Biological Matrices
2001 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats
2004
Cytochrome P-450-catalyzed dehydrogenation of 1,4-dihydropyridines.
1988
Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative Care
2005
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
Regio- and Enantioselective Alkane Hydroxylation with Engineered Cytochromes P450 BM-3
2003 StandoutNobel
Heme-Containing Oxygenases
1996 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Oxidative and reductive metabolism by cytochrome P450 2E1
1992
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of J.F. Ménez being referenced
Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
1997
Lipids and fatty acids of tachyzoites and purified pellicles ofToxoplasma gondii
1991
Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human livermicrosomes
1996
P450 2E1 expression in liver, kidney, and lung of rats treated with single or combined inducers
1996
Cytochromes P4502E1 and P4501A1 Genotypes and Susceptibility to Cirrhosis or Upper Aerodigestive Tract Cancer in Alcoholic Caucasians
1996
Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans
1997
Validation of the (ω-l)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1
1995
Evidence That Cytochrome-P450 2E1 Is Involved in the (ω-1)-Hydroxylation of Lauric Acid in Rat Liver Microsomes
1994
Ethanol‐Inducible Cytochrome P‐450: Assessment of Substrates' Specific Chemical Probes in Rat Liver Microsomes
1990
Determination of free acetaldehyde in blood as the dinitrophenylhydrazone derivative by high-performance liquid chromatography
1986
PHOSPHORYLATION OF CYTOCHROME P4502E1 (CYP2E1) BY CALMODULIN DEPENDENT PROTEIN KINASE PROTEIN KINASE C AND cAMP DEPENDENT PROTEIN KINASE
1993
Involvement of Cytochrome P450 3A4 Enzyme in the N-Demethylation of Methadone in Human Liver Microsomes
1996
Simultaneous radiometric and fluorimetric detection of lauric acid metabolites using high-performance liquid chromatography following esterification with 4-bromomethyl-6,7-dimethoxycoumarin in human and rat liver microsomes
1996
EFFECTS OF VARIOUS CYTOCHROME <italic>P</italic>-450 INDUCERS ON TESTOSTERONE METABOLISM AND SEVERAL MONOOXYGENASE ACTIVITIES IN SPRAGUEDAWLEY (SpD), HIGH ALCOHOL SENSITIVITY (HAS) AND LOW ALCOHOL SENSITIVITY (LAS) RATS
1995
Quantitative gas chromatographic determination of low-molecular-weight straight-chain carboxylic acids as their p-bromophenacyl esters after extractive alkylation in acidic medium
1981